The FDA announced on Oct. 11, 2019, that X-Gen Pharmaceuticals Inc. is recalling Levetiracetam Injection due to incorrect or missing package inserts. The recall affects 25,120 vials distributed nationwide.
How to tell if you have it
- Brand: X-Gen Pharmaceuticals
- Product: Levetiracetam Injection, 500 mg/5mL
- Packaging: 10 single-use 5 mL vials
- NDC: 39822-4000-1
- Lot codes: 7603333, 7603334, 7603335 (Exp 05/2020); 7051107 (Exp 01/2022)
- Quantity: 25,120 vials
- Distribution: U.S.A. Nationwide
The hazard
The recall is due to labeling issues where an incorrect package insert version was attached to the product.
Context
GovInfoNow's records show X-Gen Pharmaceuticals Inc. has had six other recalls since July 17, 2014. Other recent recalls of similar products include X-Gen Cyclophosphamide Injection (April 2, 2024), X-Gen Neomycin Sulfate Tablets (March 19, 2021), and X-Gen Clonidine Injection (March 29, 2019). Other recent recalls of similar products include American Regent Levocarnitine Injection (April 16, 2026), Xyvona (Levorphanol) 2mg Tablet (May 22, 2026), and ICU Medical Potassium Chloride Injection (Oct. 29, 2025).